Esophageal cancer (EC)

Clinical trials for Esophageal cancer (EC) explained in plain language.

Never miss a new study

Get alerted when new Esophageal cancer (EC) trials appear

Sign up with your email to follow new studies for Esophageal cancer (EC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

A phase 1 theranostic study to investigate safety, tolerability, pharmacokinetics, and efficacy of SKL35501, an Alpha-Emitting radiopharmaceutical targeting NTSR1, with SKL35502 as companion imaging agent in adult patients with selected advanced solid tumors

Recruiting now

This Phase 1, open-label study will evaluate two investigational radiopharmaceuticals in adults with selected advanced or metastatic solid tumors. SKL35502 is an imaging agent used with SPECT scans to identify tumors with neurotensin receptor 1 (NTSR1), a protein found on some ca…

Matched conditions: ESOPHAGEAL CANCER (EC)

Phase 1 • Sponsor: SK Life Science, Inc.

Last updated Sep 10, 2026 16:00 UTC

Esophageal cancer (EC)

Get alerted when new Esophageal cancer (EC) trials appear

A phase 1 theranostic study to investigate safety, tolerability, pharmacokinetics, and efficacy of SKL35501, an Alpha-Emitting radiopharmaceutical targeting NTSR1, with SKL35502 as companion imaging agent in adult patients with selected advanced solid tumors